Therapeutic Advances In Chronic Disease

Therapeutic Advances In Chronic Disease

慢性病的治疗进展

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Therapeutic Advances In Chronic Disease》是由SAGE Publications Inc.出版社于2010年创办的英文国际期刊(ISSN: 2040-6223,E-ISSN: 2040-6231),该期刊长期致力于药学领域的创新研究,主要研究方向为Medicine-Medicine (miscellaneous)。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.6952...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比69.62%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在79篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Therapeutic Advances In Chronic Disease审稿周期约为 12 Weeks 。该刊近年未被列入国际预警名单,年发文量约79篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 79 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 118 / 354

66.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 116 / 354

67.37%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.2 SJR:1.031 SNIP:0.857
学科类别 分区 排名 百分位
大类:Medicine 小类:Medicine (miscellaneous) Q1 81 / 398

79%

期刊发文

  • Degree of obesity and gastrointestinal adverse reactions influence the weight loss effect of liraglutide in overweight or obese patients with type 2 diabetes

    Author: Zhou, Fang; Jiang, Lu; Guo, Jiamei; Fan, Yuting; Pan, Qin; Li, Tianlian; Sun, Xiaoshi; Li, Ping

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231161516

  • Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies

    Author: Zhou, Ben-Gang; Mei, Yu-Zhou; Wang, Jing-Shu; Xia, Jian-Lei; Jiang, Xin; Ju, Sheng-Yong; Ding, Yan-Bing

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231155119

  • Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention

    Author: Zhao, Xueyan; Wang, Junmei; Yang, Jingang; Chen, Tiange; Song, Yanan; Li, Xiang; Xie, Guotong; Gao, Xiaojin; Xu, Haiyan; Gao, Runlin; Yuan, Jinqing; Yang, Yuejin

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231158561

  • Time-domain full-field optical coherence tomography (TD-FF-OCT) in ophthalmic imaging

    Author: Zhang, Jinze; Mazlin, Viacheslav; Fei, Keyi; Boccara, Albert Claude; Yuan, Jin; Xiao, Peng

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231170146

  • Ocular microvascular alteration in Sjogren's syndrome treated with hydroxychloroquine: an OCTA clinical study

    Author: Yu, Chao; Zou, Jie; Ge, Qian-Min; Liao, Xu-Lin; Pan, Yi-Cong; Wu, Jie-Li; Su, Ting; Zhang, Li-Juan; Liang, Rong-Bin; Shao, Yi

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231164498

  • The early diagnostic value of optical coherence tomography (OCT) and OCT angiography in thyroid-associated ophthalmopathy

    Author: Xu, Bei; Wang, Sha; Chen, Lu; Tan, Jia

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231166802

  • Emerging roles of macrophages in heart failure and associated treatment approaches

    Author: Xie, Lan; Chen, Jinyong; Wang, Yidong; Jin, Chengjiang; Xie, Yao; Ma, Hong; Xiang, Meixiang

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231168755

  • Periprocedural, short-term, and long-term outcomes following transcatheter tricuspid valve repair: a systemic review and meta-analysis

    Author: Wu, Zexuan; Zhu, Wengen; Kaisaier, Wulamiding; Kadier, Miriding; Li, Runkai; Tursun, Gulpari; Dong, Yugang; Liu, Chen; Chen, Yili

    Journal: THERAPEUTIC ADVANCES IN CHRONIC DISEASE. 2023; Vol. 14, Issue , pp. -. DOI: 10.1177/20406223231158607